Sitemap
Meet Us
Release
- Nanobiotix reports ‘proof of concept’ for its nanoparticles in treating glioblastoma multiforme (brain cancer)
- Nanobiotix enters into collaboration with “SonoDrugs” consortium
- Nanobiotix announces issue of European patent protecting its nanoXray anticancer platform
- Nanobiotix and BiotechCorp announce initial focus of their collaboration
- Nanobiotix CEO Dr. Laurent Lévy is elected co-president of the French Technology Platform on Nanomedicine (FTPN)
- Nanomedicine company Nanobiotix elects former Sanofi-Aventis oncology researcher Elsa Borghi, MD, as its medical director
- Nanomedicine company Nanobiotix elects former Aventis vice chairman and CFO Patrick Langlois as its chairman